Isojacareubin - CAS 50597-93-8

Isojacareubin displays potent activity against H. pylori HP40 clinical isolate with MIC 23.9 uM, which is approximately two times greater than that of the standard drug amoxicillin. Isojacareubin is a potent inhibitor of protein kinase C (PKC), suppresses hepatocellular carcinoma metastasis and induces apoptosis in vitro and in vivo, thus, it as a promising lead compound for the development of new antihepatoma agents.

PKC, Apoptosis, Antifection, MAPK, SARS-CoV, Antibacterial

Chromatin/Epigenetic, Apoptosis, MAPK, Cytoskeletal Signaling, Microbiology/Virology

50496

C18H14O6

326.304

CC1(C)Oc2cc(O)c3c(oc4c(O)c(O)ccc4c3=O)c2C=C1 |c:25|

-20°C

Ice Packs

Natural Product